BRD2 and colorectal carcinoma: Using methyl capture sequencing data [23] (6 NAT, 15 adenoma and 9 CRC samples), significant hypomethylation of predicted LINC00152 promoter was determined in CRC compared to NAT samples (p = 0.0011).